BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Treatment
307 results:

  • 1. Temporal trends and regional variability in BRAF and KRAS genetic testing in Denmark (2010-2022): Implications for precision medicine.
    Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Decoding the Versatile Landscape of Autophagic Protein VMP1 in cancer: A Comprehensive Review across Tissue Types and Regulatory Mechanisms.
    Renna FJ; Gonzalez CD; Vaccaro MI
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612567
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Compound 225# inhibits the proliferation of human colorectal cancer cells by promoting cell cycle arrest and apoptosis induction.
    Zhang X; He L; Li Y; Qiu Y; Hu W; Lu W; Du H; Yang D
    Oncol Rep; 2024 May; 51(5):. PubMed ID: 38577924
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Discovery of novel urea derivatives as ferroptosis and autophagy inducer for human colon cancer treatment.
    Liang T; Dong H; Wang Z; Lu L; Song X; Qi J; Zhang Y; Wang J; Du G
    Eur J Med Chem; 2024 Mar; 268():116277. PubMed ID: 38422700
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [treatment Strategy for Familial Adenomatous Polyposis Presenting with Obstructive colorectal cancer and Concurrent Liver Metastasis].
    Yoshida K; Ushigome M; Yamazaki N; Yamakawa T; Miura Y; Suzuki T; Kagami S; Kaneko T; Kurihara A; Tochigi N; Funahashi K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1396-1398. PubMed ID: 38303286
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [A Case of Conversion Surgery after Chemotherapy for Unresectable Liver Metastasis of Rectal cancer].
    Umezu M; Goto K; Tokuyama S; Sakai K; Toshiyama R; Kawai K; Takahashi Y; Hamakawa T; Doi T; Takeno A; Kato T; Takami K; Hirao M
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1789-1791. PubMed ID: 38303208
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. scRNA-seq of colorectal cancer shows regional immune atlas with the function of cd20
    Ji L; Fu G; Huang M; Kao X; Zhu J; Dai Z; Chen Y; Li H; Zhou J; Chu X; Lei Z
    Cancer Lett; 2024 Mar; 584():216664. PubMed ID: 38253219
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. SNRPB promotes the progression of hepatocellular carcinoma via regulating cell cycle, oxidative stress, and ferroptosis.
    Wang X; Zhang H; Guo Z; Wang J; Lu C; Wang J; Jin R; Mo Z
    Aging (Albany NY); 2024 Jan; 16(1):348-366. PubMed ID: 38189879
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Repurposing Metabolic Inhibitors in the treatment of Colon Adenocarcinoma Patient-Derived Models.
    Lee B; Lee C; Moon HM; Jo SY; Jang SJ; Suh YA
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132178
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
    Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
    BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Improvement of Severe Colon Stricture after Rituximab Therapy for Concomitant Mucosa-associated Lymphoid Tissue Lymphoma in a Patient with Ulcerative Colitis.
    Park HJ; Moon W; Park SJ; Park MI; Kim SE; Kim JH; Jung K; Seo KI; Lee EM; Jung M
    Korean J Gastroenterol; 2023 Nov; 82(5):254-260. PubMed ID: 37997222
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
    Sohel M
    Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Zhang S; Li N; Wang F; Liu H; Zhang Y; Xiao J; Qiu W; Zhang C; Fan X; Qiu M; Li M; Tang H; Fan S; Wang J; Luo H; Li X; Lin J; Huang Y; Liang L
    Pharmacol Res; 2023 Nov; 197():106974. PubMed ID: 37898442
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Complete pathologic response after laparoscopic hepatectomy following treatment with nivolumab and ipilimumab for anticancer drug-resistant MSI-high colon cancer liver metastasis consisting of poorly differentiated adenocarcinoma with squamous differentiation: A case report.
    Kato M; Sawayama H; Komohara Y; Hisano Y; Nakamura H; Ohuchi M; Ogawa K; Miyamoto Y; Yoshida N; Baba H
    Clin J Gastroenterol; 2024 Feb; 17(1):57-64. PubMed ID: 37874527
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Deficiency of SR-B1 reduced the tumor load of colitis-induced or APC
    Chen Q; Wang L; Song H; Xing W; Shi J; Li Y; Wang Z; Chen J; Xie N; Zhao W
    Cancer Med; 2023 Oct; 12(19):19744-19757. PubMed ID: 37766594
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Anticancer Study of a Novel Pan-HDAC Inhibitor MPT0G236 in colorectal cancer Cells.
    Tsai FL; Huang HL; Lai MJ; Liou JP; Pan SL; Yang CR
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628767
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in colorectal cancer and Invasive Breast cancer.
    Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
    Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Circ_0001589/miR-1248/HMGB1 axis enhances EMT-mediated metastasis and cisplatin resistance in cervical cancer.
    Ma T; Guo J; Han J; Li L; Ren Y; Huang J; Diao G; Zheng X; Zheng Y
    Mol Carcinog; 2023 Nov; 62(11):1645-1658. PubMed ID: 37431919
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling.
    Park SY; Seo D; Jeon EH; Park JY; Jang BC; Kim JI; Im SS; Lee JH; Kim S; Cho CH; Lee YH
    Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37387446
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer.
    Li J; Wu C; Hu H; Qin G; Wu X; Bai F; Zhang J; Cai Y; Huang Y; Wang C; Yang J; Luan Y; Jiang Z; Ling J; Wu Z; Chen Y; Xie Z; Deng Y
    Cancer Cell; 2023 Jun; 41(6):1152-1169.e7. PubMed ID: 37172580
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.